Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Evaxion Biotech A/S ADR
(NQ:
EVAX
)
3.770
-0.100 (-2.58%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evaxion Biotech A/S ADR
< Previous
1
2
3
4
5
6
Next >
Evaxion announces financing commitments totaling up to USD 20 million with Negma Group
August 01, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
July 31, 2023
From
Evaxion Biotech
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 06, 2023
Via
Benzinga
Why Are Evaxion Biotech Shares Trading Higher Today
June 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
June 05, 2023
Gainers Forza X1, Inc. (NASDAQ: FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 05, 2023
It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial
June 03, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Announces Business Update and First Quarter 2023 Financial Results
May 31, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion unveils proprietary genetic adjuvant technology to boost the effect of DNA and mRNA vaccines
May 25, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion announces promising clinical Phase 1 data for its personalized cancer vaccine EVX-01
May 25, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion to host R&D Day on May 25, 2023
May 16, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Fourth quarter and full year 2022 financial results and business update
April 27, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients
April 18, 2023
Via
Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...
Via
Benzinga
Evaxion announces promising clinical data for DNA-based personalized cancer immunotherapy EVX-02: Phase 1/2a trial met both primary and secondary endpoints
April 18, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform
April 13, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients
March 28, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
March 23, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for Cancer Research Annual Meeting (AACR)
March 14, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
March 06, 2023
On Monday, 36 companies set new 52-week lows.
Via
Benzinga
Evaxion Biotech, Pantherna Reveals Encouraging Data From mRNA-Based Cancer Vaccine
February 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 08, 2023
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!
Via
InvestorPlace
Evaxion and Pantherna announce promising preclinical mRNA vaccine data
February 08, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion receives FDA fast-track designation for personalized cancer immunotherapy
January 19, 2023
From
Evaxion Biotech
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 03, 2023
Via
Benzinga
Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01
January 03, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.